T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-09-15	₩2,230.00	-0.89%	65,993
26-09-15	₩2,250.00	-1.96%	112,191
26-09-14	₩2,295.00	+1.55%	72,371
26-09-11	₩2,260.00	-2.38%	105,162
26-09-10	₩2,315.00	+5.47%	113,304

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 2026-09-16			5-day change	1st Jan Change
2,230.00 ^KRW	-0.89%		+0.45%	-42.97%

01-20	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
24-09-22	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	106B 77.69M 67.32M 63.63M 57.77M 108M 7.45B 109M 760M 294M 3.78B 292M 285M 12.05B	P/E 2024	-12.2x	P/E 2025	-3.91x
Enterprise Value	128B 93.55M 81.07M 76.63M 69.56M 130M 8.97B 131M 915M 353M 4.55B 351M 344M 14.51B	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	78.94%	Yield 2024 *	-	Yield 2025	-

01-20	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
24-09-22	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
24-08-04	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
24-07-22	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
24-07-03	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
24-06-24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
23-12-21	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
23-12-13	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
23-10-18	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
23-08-03	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
23-07-25	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
23-05-14	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
21-09-20	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	-0.89%
1 week	+0.45%
Current month	-1.55%
1 month	-13.40%
3 months	+6.19%
6 months	-31.70%
Current year	-42.97%

T&R Biofab Co., Ltd. Stock

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news: T&R Biofab Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

1 week	2,130	2,350
1 month	2,130	2,650
Current year	1,777	4,800
1 year	1,127	4,925
3 years	1,127	10,600
5 years	1,127	30,958.33
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Ju-Sung Sim COO	Chief Operating Officer	57	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/6/25	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
3/6/25	Eun-kyung Cho	Others		15,492	0.0719%
2/26/25	Won-Soo Yoon	Buy	Chief Executive Officer	2,100	0.0097%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	-0.89%	+0.45%	+12.91%	-78.83%	78.7M
STRYKER CORPORATION	+1.27%	+4.44%	-23.63%	-1.91%	108B
SMITH & NEPHEW PLC	+0.43%	+1.61%	-24.36%	-0.62%	11.77B
GLAUKOS CORPORATION	-5.32%	-8.70%	+99.33%	+117.33%	10.12B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.57%	-4.58%	-54.22%	-71.49%	3.97B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.25%	-5.64%	-29.26%	+21.67%	2.36B
INSPIRE MEDICAL SYSTEMS, INC.	-1.63%	+10.88%	-8.77%	-64.91%	2.16B
INSIGHT LIFETECH CO., LTD.	0.00%	-5.48%	-	-	1.82B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.19%	-3.04%	-21.91%	-30.15%	1.5B
Average	-0.68%	+0.99%	-6.24%	-13.61%	15.75B
Weighted average by Cap.	+0.58%	+1.22%	-15.49%	+3.93%

	2024	2025
Net sales	4.87B 3.56M 3.09M 2.92M 2.65M 4.96M 342M 4.99M 34.83M 13.46M 173M 13.38M 13.08M 552M	26.97B 19.71M 17.08M 16.14M 14.66M 27.47M 1.89B 27.63M 193M 74.47M 959M 74.04M 72.4M 3.06B
Net income	-7.68B -5.61M -4.86M -4.6M -4.17M -7.82M -538M -7.87M -54.88M -21.21M -273M -21.08M -20.61M -870M	-31.95B -23.35M -20.24M -19.13M -17.37M -32.55M -2.24B -32.74M -228M -88.24M -1.14B -87.73M -85.78M -3.62B
Net Debt	28.78B 21.04M 18.23M 17.23M 15.64M 29.32M 2.02B 29.49M 206M 79.48M 1.02B 79.02M 77.27M 3.26B	21.7B 15.86M 13.75M 12.99M 11.79M 22.11M 1.52B 22.24M 155M 59.93M 772M 59.58M 58.26M 2.46B